Effectiveness of a Diabetes Education Program Based on Tailored Interventions (Edep-Ti Study)
Effectiveness of a Diabetes Education Program Based on Tailored Interventions (Edep-Ti Study)
GOALS:

 PRIMARY:

 1. Analyze the overall impact of the proposed diabetes education program on metabolic
 control (HbA1c) and modifiable cardiovascular risk factors (lipid profile and blood
 pressure).

 SECONDARY:

 2. Evaluate the effectiveness of the program on smoking habits and body mass index (weight,
 height).

 3. Analyze the impact of the program on the quality of life related to health.

 4. Check the effect on lifestyles: compliance levels of physical exercise and adherence to
 diet mediterranean.

 DESIGN: Cluster randomized controlled trial
The reference population will be patients with a diagnosis of diabetes mellitus in treatment
 with oral antidiabetics, excluding the insulinized patients. They will then be randomly
 assigned by cluster, to the intervention group (individual education) or control (usual care)
 in the context of each health center participating in the project. After randomization
 centers, all professionals who decide to cooperate receive a training process on methodology
 for measuring results (clinical and questionnaire variables), while assigned to the
 experimental intervention, will also receive training on how to carry out the program of
 diabetologic education proposed. The follow-up period for both groups is 18 months obtained
 as clinical determinations: glycosylated hemoglobin (metabolic control), blood pressure,
 lipid profile, smoking and BMI; and as results reported by the patient through
 questionnaires: quality of life related to health, level of physical activity performed or
 adherence to the Mediterranean diet.
Inclusion Criteria:

 -  Patients with Type II Diabetes Mellitus diagnosed <10 years and classified in a
 computerized clinical history with poor metabolic control and in treatment with oral
 antidiabetics.

 -  HbA1c> 7% in the last control available (<1 year); or poor control of one of the
 following cardiovascular risk factors (in the last year): SBP> 140 mmHg or DBP> 90
 mmHg, or presence of tobacco habit or dyslipidemia (LDL-c > = 100 mg / dL) or BMI> 30;
 or in treatment with: ACE inhibitors, angiotensin II receptor antagonists,
 beta-blockers, calcium channel blockers or diuretics and lipid-lowering drugs.

 Exclusion Criteria:

 -  Diabetes Mellitus type 1

 -  Insulinized patients.

 -  Patients who have received some type of structured educational intervention in the
 last year according to the data obtained in their clinical history.

 -  Patients with some type of sensory or mental disability.

 -  Gestational diabetes.

 -  Patients with age equal to or greater than 75 years of age or minors.

 -  Patients with inability to travel to their Health Center.